(5Z)-5-[(1,3-benzodioxo-5-yl)methylene]-3-methyl-2-[{2-(Z)-(2,3-dihydrobenzo[1,4]dioxin-6-yl)methyleneamino}ethylamino]-3,5-dihydro-4H-imidazol-4-one

ID: ALA1081557

Chembl Id: CHEMBL1081557

PubChem CID: 135860187

Max Phase: Preclinical

Molecular Formula: C23H22N4O5

Molecular Weight: 434.45

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCC/N=C/c1ccc2c(c1)OCCO2

Standard InChI:  InChI=1S/C23H22N4O5/c1-27-22(28)17(10-15-2-4-19-21(11-15)32-14-31-19)26-23(27)25-7-6-24-13-16-3-5-18-20(12-16)30-9-8-29-18/h2-5,10-13H,6-9,14H2,1H3,(H,25,26)/b17-10-,24-13+

Standard InChI Key:  UBZKQJNEULNQDI-IDIIENHSSA-N

Alternative Forms

  1. Parent:

    ALA1081557

    ---

Associated Targets(Human)

CSNK2B Tbio Casein kinase I isoform alpha/subunit beta (18 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK5 Tchem Cyclin-dependent kinase 5/CDK5 activator 1 (3697 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3A Tclin Glycogen synthase kinase-3 (736 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 434.45Molecular Weight (Monoisotopic): 434.1590AlogP: 2.06#Rotatable Bonds: 5
Polar Surface Area: 93.98Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.13CX LogP: 2.14CX LogD: 2.11
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.44Np Likeness Score: -0.56

References

1. Debdab M, Renault S, Lozach O, Meijer L, Paquin L, Carreaux F, Bazureau JP..  (2010)  Synthesis and preliminary biological evaluation of new derivatives of the marine alkaloid leucettamine B as kinase inhibitors.,  45  (2): [PMID:19879673] [10.1016/j.ejmech.2009.10.009]

Source